Table 1 Summary of Participant Characteristics
Characteristic | Concept Elicitation Interviews (N = 30) | Cognitive Interviews (N = 20) |
|---|---|---|
Age, mean years (SD) | 64.5 (11.4) | 64.9 (8.3) |
Gender, n (%)1 | ||
Male | 16 (53.3%) | 9 (45.0%) |
Female | 13 (43.3%) | 11 (55.0%) |
Ethnicity, n (%)1 | ||
Hispanic or Latino | 2 (6.7%) | 1 (5.0%) |
Not Hispanic or Latino | 26 (86.7%) | 19 (95.0%) |
Race, n (%) | ||
Black or African American | 7 (23.3%) | 6 (30.0%) |
White | 23 (76.7%) | 14 (70.0%) |
Other2 | 1 (3.3%) | -- |
Employment status, n (%) | ||
Full-time work | 5 (16.7%) | 5 (25.0%) |
Part-time work | 2 (6.7%) | -- |
Other3 | 23 (76.7%) | 15 (75.0%) |
Education level, n (%) | ||
University degree | 9 (30.0%) | 7 (35.0%) |
No university degree | 21 (70.0%) | 13 (65.0%) |
Marital status, n (%) | ||
Single | 7 (23.3%) | 3 (15.0%) |
Married/Cohabitating/Living with partner | 16 (53.3%) | 12 (60.0%) |
Other4 | 7 (23.3%) | 5 (25.0%) |
Duration of diabetes, mean years (SD) | 18.1 (10.6) | 12.9 (8.6) |
Most recent HbA1c (%), mean (SD)5 | 7.3 (1.0) | 8.4 (2.5) |
BMI, mean kg/m2(SD) | 32.9 (6.4) | 35.3 (8.5) |
Current treatment, n (%) | ||
Oral only | 3 (10.0%) | 5 (25.0%) |
Insulin | 4 (13.3%) | 2 (10.0%) |
Injectable GLP-1 RA | 1 (3.3%) | -- |
Oral and insulin | 12 (40.0%) | 7 (35.0%) |
Oral and injectable GLP-1 RA | 6 (20.0%) | 2 (10.0%) |
Insulin and injectable GLP-1 RA | 2 (6.7%) | 2 (10.0%) |
Oral, insulin, and injectable GLP-1 RA | 2 (6.7%) | 2 (10.0%) |